Stock Price Quote

KILITCH DRUGS (INDIA) LTD.

NSE : KILITCHBSE : 524500ISIN CODE : INE729D01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE261.3027.8 (+11.91 %)
PREV CLOSE ( ) 233.50
OPEN PRICE ( ) 243.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 59828
TODAY'S LOW / HIGH ( )238.15 267.70
52 WK LOW / HIGH ( )121.1 248.25
NSE260.7026.96 (+11.53 %)
PREV CLOSE( ) 233.74
OPEN PRICE ( ) 244.00
BID PRICE (QTY) 260.70 (811)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 661834
TODAY'S LOW / HIGH( ) 236.30 267.80
52 WK LOW / HIGH ( )117.25 248.3
BSE NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1992
Management Info
- Chairman Mukund Mehta - Managing Director
Registered Office

Address C 301/2 M I D C,T T C Industrial Area,Pawane Village,
Navi Mumbai,
Maharashtra-400705

Phone 022-62996300

Email info@kilitch.com

Website www.kilitch.com

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

17Jun Kilitch Drugs commences Nutraceutical
Kilitch Drugs (India) has commenced the Nutraceutical Manufacturing Bloc..
27May Kilitch Drugs India informs about annu
Pursuant to Regulation 24A of SEBI (Listing Obligation and Disclosure Re..
07May Kilitch Drugs India informs about boar
Kilitch Drugs India has informed that the meeting of the Board of Direct..
25Mar Kilitch Drugs (India) informs about cl
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as..
17Mar Kilitch Drugs (India) informs about re
Pursuant to the Regulation 42 of SEBI (Listing Obligations and Disclosur..
MORE

Financials

in Millions
QTR Jun 26 ANNUAL 26
Net Profit50.52324
Gross Profit 69.48 415.54
Operating Profit 81.93462.85
Net Sales 409.121885.74
MORE

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Divi's Laboratories (BSE)
peergroup  9545.00 (3.61%)
M.Cap ( in Cr)253044.65
Bharat Parenterals (BSE)
peergroup  1842.35 (6.66%)
M.Cap ( in Cr)1304.51
Wockhardt (BSE)
peergroup  2174.10 (5.46%)
M.Cap ( in Cr)35329.05
Kwality Pharma (BSE)
peergroup  3751.20 (3.01%)
M.Cap ( in Cr)3915.98
Gland Pharma (BSE)
peergroup  3006.90 (3.22%)
M.Cap ( in Cr)49701.27
MORE

Shareholding Pattern

PROMOTERS 63.77%
NON-INSTITUTION 36.11%
FI/BANKS/INSURANCE 0%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%
MORE

About Kilitch Drugs (India) Ltd.

Kilitch Drugs (India) Ltd. was incorporated in the year 1992. Its today's share price is 261.3. Its current market capitalisation stands at Rs 915.29 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1885.74 Cr and Total Income of Rs.2024.28 Cr. The company's management includes Pushpa Nyoupane, Dipen J Jain, V S Rajan, Vasudev Krishnamurti, Bhavin Mehta, Mira Mehta, Mukund Mehta.

It is listed on the BSE with a BSE Code of 524500 , NSE with an NSE Symbol of KILITCH and ISIN of INE729D01010. It's Registered office is at C 301/2 M I D C,T T C Industrial Area,Pawane VillageNavi Mumbai-400705, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are AM Ghelani & Co, C Sharat & Associates, RNR Iyer & Co, Suryaprakash Maurya & Co

download beyond app
About Nirmal Bang About Nirmal Bang Awards & Accolades Careers at Nirmal Bang Contact Nirmal Bang
Product & Services Equity & Derivatives Trading Forex Trading Commodity Trading Institutional Broking Depository Services Loan Against Securities (LAS) Algo Trading
Equity Price Analysis Volume Analysis Index Analysis News Analysis Corporate Action India Market Other Market Share Market Holidays
Derivatives Updates Market Report Overview
IPO IPO Issues Performance News & Analysis
Commodities Market Movers News & Commentary MCX / NCDEX Holidays
Mutual Funds About Nirmal Bang Niveshalaya Why Associate with Nirmal Bang Mutual Fund Login Mutual Fund Register FAQs Mutual Fund Holidays SIP Calculator Mutual Funds Updates Mutual Funds Trends Mutual Fund Reports Annual Return 2018 Annual Return 2017 Mutual Fund Terms & Conditions Mutual Privacy Policy
Nirmal Bang Research Technical Calls Equity Reports Commodity Reports Currency Research Institutional Research
Nirmal Bang Media Knowledge Center Blog Support Center Become A Partner Beyond Market Careers Sitemap
Other Links Disclaimer Privacy Policy Terms Of Use Rules & Regulations Disclosures Grievances SEBI ScoresRMS Policy
Connect with Us
ATTENTION INVESTORS Depository IPO KYC
Inactive account treatmentNBSPL Policy of AMLNBEPL Policy of AMLNBCPL Policy of AMLNBSPL CSR Policy Physical Settlement Policy of Derivative Aadhar UpdationNirmalbang Privacy Policy V1.0 Documents in Vernacular Languages NBSPL Disclosure Document March 2019
Nirmal Bang Securities Pvt. Ltd. : Member NSE – ID 09391, SEBI Registration No. NSE CM Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE FO Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE CDS Segment INZ000202536, Member NSE Commodity – ID 09391, SEBI Registration No. NSE COMMODITY Segment Exchange Registered Broker, Member MSEI – ID 1067, SEBI Registration No. MSEI CM Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI FO Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI CDS Segment INZ000202536, Member MCX – ID 56460, SEBI Registration No. MCX COMMODITY Segment INZ000202536, Member NCDEX – ID 1268, SEBI Registration No. NCDEX COMMODITY Segment NZ000202536, Member ICEX – ID 2073, SEBI Registration No. ICEX COMMODITY Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CM Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE FO Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CDS Segment Exchange Registered Broker, Member BSE Commodity – ID 0498, SEBI Registration No. BSE COMMODITY Segment Exchange Registered Broker, SEBI Registration No. PMS INP000002981, SEBI Registration No. Research Analyst INH000001766, Nirmal Bang Securities: ARN-49454, SEBI Registration No. DP Participants NSDL – CDSL IN-DP-CDSL 37-99,Member Comtrack Participant Id – ID 50274, Member NERL RP Id– ID R1447, Nirmal Bang Equities Private Limited Member BSE – ID 245, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. NSE FO Segment INZ000186135, Member NSE Currency – ID 13437, SEBI Registration No. NSE CDS Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI CM Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI FO Segment INZ000186135, SEBI Registration No. Research Analyst Segment INH000001436, Nirmal Bang Commodities Private Limited Member MCX – ID 16590, SEBI Registration No. MCX COMMODITY Segment INZ000043630, Member NCDEX – ID 00362, SEBI Registration No. NCDEX COMMODITY Segment INZ000043630, Member ICEX – ID 1165, SEBI Registration No. ICEX COMMODITY Segment INZ000043630, Member NCDEX Spot Exchange – ID 10084,Comtrack Participant CPID -5040, Participant CDSL Commodity Repository Limited - 12013300
For any grievances, please get in touch on 022-62739390 and write a mail to Contact@nirmalbang.com with Subject line as Grievances/Complain.     |    

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

AppleApp Store GooglePlay Store
AppleApp StoreGooglePlay Store
Support
Videos